Donafenib as a first-line monotherapy for advanced hepatocellular carcinoma.
Hepatobiliary Surg Nutr
; 10(5): 737-740, 2021 Oct.
Article
in En
| MEDLINE
| ID: mdl-34760990
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Hepatobiliary Surg Nutr
Year:
2021
Document type:
Article
Affiliation country:
China